Quantcast

Latest Northwest Biotherapeutics Stories

2015-04-20 08:29:39

DCVax-L and DCVax-Direct Both To Be the Subject of Presentations Today BETHESDA, Md., April 20, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.

2015-04-16 08:30:46

NW Bio Currently Ranked 8th Among the 25 Companies BETHESDA, Md., April 16, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.

2015-04-02 12:32:31

Further Equity Investment By Woodford Funds BETHESDA, Md., April 2, 2015 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.

2015-03-24 12:32:30

BETHESDA, Md., March 24, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies

2015-02-19 12:28:28

BETHESDA, Md., Feb. 19, 2015 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.

2015-02-06 08:25:31

BETHESDA, Md., Feb. 6, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a U.S.

2015-01-23 12:24:47

BETHESDA, Md., Jan. 23, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)("NW Bio"), a U.S.

2015-01-08 16:26:43

BETHESDA, Md., Jan. 8, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a U.S.

2014-11-19 16:26:33

Funding Includes $25 Million Equity Investment By Leading UK Investment Fund and $10 Million Mortgage Financing BETHESDA, Md., Nov.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related